Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma
NCT06551272
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
EXL01
Sponsor
Center Eugene Marquis